Chemically Induced Hepatocellular Carcinoma and Stages of Development with Biochemical and Genetic Modulation: A Special Reference to Insulin-Like-Growth Factor II and Raf Gene Signaling

Documents similaires

• Insulin Use and The Risk of Hepatocellular Carcinoma: Insights and Implications
  par: Juferdy Kurniawan, et autres
  Publié: (2024-04-01)
• A diaryl urea derivative, SMCl inhibits cell proliferation through the RAS/RAF/MEK/ERK pathway in hepatocellular carcinoma
  par: Yue Fu, et autres
  Publié: (2025-07-01)
• Role of insulin-like growth factor, pro-inflammatory and anti-inflammatory cytokines, transcription factors and adipokines in development of hepatocellular carcinoma in metabolic syndrome
  par: O. V. Smirnova, et autres
  Publié: (2022-12-01)
• Immunohistochemical analysis of insulin‐like growth factor I, insulin‐like growth factor I receptor and insulin‐like growth factor II in endometriotic tissue and endometrium
  par: Shiuh Y. Chang, et autres
  Publié: (1997-02-01)
• Hepatocellular carcinoma with regional lymphadenopathy caused by sarcoid-like reaction: a case report
  par: Tomoko Mizota, et autres
  Publié: (2021-03-01)